HealthTech & Digital Health Startups

P

Prickly Pear Health

United States

Prickly Pear Health is a digital health company focused on women's brain health during menopausal transition and hormonal shifts. Its AI-powered platform delivers personalized, actionable insights to support mental clarity, emotional wellbeing, and cognitive resilience by decoding connections between feelings and body signals. The product targets women experiencing hormonal changes and healthcare providers seeking better tools for brain health monitoring and intervention. Founded in 2024 and based in Phoenix, Arizona, the company emphasizes AI-driven personalization in femtech and healthtech contexts.

R

Rymo Technologies

India

Rymo Technologies is a Navi Mumbai-based health-tech startup founded in 2020 that transforms physical rehabilitation through robotics, virtual reality, and AI. Its flagship Mobi-L system is a compact robotic mobility trainer for upper and lower limb neuro-rehabilitation, supporting stroke recovery and neurological conditions. The company serves over 452 clinical installations including AIIMS, Apollo Hospitals, and Manipal Hospitals, and has received US FDA Class II medical device classification.

F

Flora Fertility

United States

The first individually-owned fertility insurance solution. Available directly to individuals or via employers. | At Flora Fertility, we're on a mission to empower the next generation of parents, by putting control of your reproductive health outcomes back where it belongs: in your hands. By creating the first indivdually-owned fertility benefits solution, we're revolutionizing the way women's health and family building are funded. With affordable insurance options and a supportive community, Flora is breaking down barriers and making fertility care more accessible to all.

I

Insight Health

United States

Insight Health builds AI assistants for healthcare organizations that automate administrative workflows including fax processing, referral management, and prior authorization. The company addresses the healthcare industry's heavy reliance on outdated communication methods like fax machines, enabling clinical staff to focus on patient care rather than paperwork.

A

Ambient Clinical Analytics

United States

Healthcare technology company combining real-time clinical analytics with clinical decision support and workflow tools. Its FDA Class II-cleared and CE-marked AWARE platform turns clinical data into actionable insights to help clinicians detect patient deterioration and coordinate care delivery across bedside, command center, and remote monitoring environments.

J

Jimini Health

United States

Jimini Health is a New York-based AI behavioral health platform that provides clinically supervised mental healthcare tools. The company builds patient-facing AI chatbot infrastructure for mental health providers, enabling clinically safe AI interactions alongside human care. Founded to address the growing demand for scalable behavioral health support with clinical oversight.

V

Vivatides Therapeutics

China

Next generation RNA therapeutics to benefit patients lives | Next generation RNA therapeutics to benefit patients' lives

I

Intu Diagnostics

Germany

Intu Diagnostics is a Leipzig-based molecular diagnostics company and Fraunhofer IZI spin-off developing a fully lab-free, electricity-free testing platform that brings molecular-grade infectious disease testing to the point of care, including the home. Its first application targets HPV testing in women's health, with a platform designed to adapt across multiple infectious diseases for decentralised testing in low-resource settings. The company was founded in 2023 by Skaiste Arbaciauskaite and Dirk Kuhlmeier based on technology patented at the Fraunhofer Institute for Cell Therapy and Immunology.

L

Lucida Medical

United Kingdom

Lucida Medical is a Cambridge-based AI medtech company that develops artificial intelligence software to support the detection, diagnosis, and management of cancer. Its flagship product, Pi (Prostate Intelligence), is a CE-marked medical device that analyses prostate MRI scans to identify suspicious lesions and generate risk scores, assisting radiologists in detecting clinically significant prostate cancer. The system is trained on thousands of patient scans and is deployed across multiple NHS hospitals in the UK, with EU approval and plans to seek US FDA approval. Founded in 2019 by Anthony and Evis Sala.